5th Edition of World Nursing Research Conference 2026

Background: Approximately 34-67 percent of cancer patients experience an episode of uncontrolled pain during the course of their disease, depending on the stage.

Aims: to provide real world data for pain prevalence, diagnosis and treatment recommendations on integrative model of medical oncology and palliative care for patients with cancer diagnostic in a day hospital, we made also a short review of the pain treatment summary published in Academia Edu.

Patients and method

Consultation register and electronic records of 166 Patients (Pts) were studied from April 2023 to March 2025. Pts with pain syndrome were selected. The pain was objectified by the visual pain scale. To elucidate the causes of the pain investigations were carried out: bone scintigraphy, CT scan, PET-CT. The analgesic treatments was represented by week and strong morphine, radiotherapy, bisphosphonates, non-morphine drug combination. We try to understand and we also tried to assess the preference for treatment of the patients and why they refuse opioid treatment.

Result

During the mentioned period, 166 oncological patients (74 women and 92 men) were treated in the oncology day hospitalization service. There were 1,500 consultations, 40 of which were only for pain. The neoplastic locations were: gynecological, malignant melanoma, breast, gastric, bronchopulmonary, colorectal, liver, pancreatic, bladder, kidney. 70 Pts presented pain syndrome. The causes of the pain were represented by bone metastases, compressive tumors, post-surgical status.

Drug treatment: Tramadol or tramadol with paracetamol (Doreta) 47 Pts of which 3 switched to a major opioid (Oxycodonum, Morphine sulfate), 5 Pts were treated with Oxycodonum as the first intention.

Other drugs therapy administrated with morphine agents or in nonmorphynic combination were: Midazolam plus am nonsteroidal anti-inflammatory drug, Alprazolam, Lorazepam, Metilprednisolon, bisphosphonates .

Refusal of opioid treatment was encountered in 7 patients who argued that they were afraid of depressing their breathing or that therapy with morphine derivatives was the last stage before death.